469 related articles for article (PubMed ID: 12949815)
1. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract][Full Text] [Related]
2. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.
Su SL; Huang IP; Fair WR; Powell CT; Heston WD
Cancer Res; 1995 Apr; 55(7):1441-3. PubMed ID: 7882349
[TBL] [Abstract][Full Text] [Related]
3. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating prostate tumor cells: alternative spliced variant of PSM induced false-positive result.
Hisatomi H; Nagao K; Kawakita M; Matsuda T; Hirata H; Yamamoto S; Nakamoto T; Harasawa H; Kaneko N; Hikiji K; Tsukada Y
Int J Mol Med; 2002 Nov; 10(5):619-22. PubMed ID: 12373303
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific membrane antigen and its truncated form PSM'.
Mlcochová P; Barinka C; Tykvart J; Sácha P; Konvalinka J
Prostate; 2009 Apr; 69(5):471-9. PubMed ID: 19107881
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.
Kawakami M; Nakayama J
Cancer Res; 1997 Jun; 57(12):2321-4. PubMed ID: 9192800
[TBL] [Abstract][Full Text] [Related]
7. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.
Grauer LS; Lawler KD; Marignac JL; Kumar A; Goel AS; Wolfert RL
Cancer Res; 1998 Nov; 58(21):4787-9. PubMed ID: 9809977
[TBL] [Abstract][Full Text] [Related]
8. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
Heston WD
Urology; 1997 Mar; 49(3A Suppl):104-12. PubMed ID: 9123729
[TBL] [Abstract][Full Text] [Related]
9. Analysis of prostate-specific membrane antigen splice variants in LNCap cells.
Williams T; Kole R
Oligonucleotides; 2006; 16(2):186-95. PubMed ID: 16764542
[TBL] [Abstract][Full Text] [Related]
10. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
[TBL] [Abstract][Full Text] [Related]
11. Real-time quantitative RT-PCR assay of prostate-specific antigen and prostate-specific membrane antigen in peripheral blood for detection of prostate cancer micrometastasis.
Zhang L; Wang CY; Yang R; Shi J; Fu R; Chen L; Klocker H; Zhang J
Urol Oncol; 2008; 26(6):634-40. PubMed ID: 18367130
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor variants occur frequently in castration resistant prostate cancer metastases.
Zhang X; Morrissey C; Sun S; Ketchandji M; Nelson PS; True LD; Vakar-Lopez F; Vessella RL; Plymate SR
PLoS One; 2011; 6(11):e27970. PubMed ID: 22114732
[TBL] [Abstract][Full Text] [Related]
13. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
[TBL] [Abstract][Full Text] [Related]
14. [Significance of prostate-specific membrane antigen (PSMA). A neurocarboxypeptidase and membrane folate hydrolase].
Heston WD
Urologe A; 1996 Sep; 35(5):400-7. PubMed ID: 8999630
[TBL] [Abstract][Full Text] [Related]
15. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific membrane antigen-derived primers in a nested reverse transcription polymerase chain reaction for detecting prostatic cancer cells.
Saimoto A; Saito S; Murai M
Jpn J Cancer Res; 1999 Feb; 90(2):233-9. PubMed ID: 10189895
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cells show a nearly 100-fold increase in the expression of the longer of two alternatively spliced mRNAs of the prostate-specific membrane antigen (PSM).
Weissensteiner T
Nucleic Acids Res; 1998 Jan; 26(2):687. PubMed ID: 9480454
[No Abstract] [Full Text] [Related]
18. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model.
Schmittgen TD; Zakrajsek BA; Hill RE; Liu Q; Reeves JJ; Axford PD; Singer MJ; Reed MW
Prostate; 2003 Jun; 55(4):308-16. PubMed ID: 12712410
[TBL] [Abstract][Full Text] [Related]
19. Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.
Koutsilieris M; Lembessis P; Luu-The V; Sourla A
Clin Exp Metastasis; 1999; 17(10):823-30. PubMed ID: 11089880
[TBL] [Abstract][Full Text] [Related]
20. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
Noguchi M; Miyajima J; Itoh K; Noda S
Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
